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ABSTRACT
￿
Lysosomotropic amines are believed to inhibit the transport of diphtheria toxin to
the cell cytoplasm by raising the pH within intracellular vesicles. If so, then other drugs that
dissipate intracellular proton gradients should have a similar effect on toxin transport. We
found that monensin, a proton ionophore unrelated to lysosomotropic amines, is a potent
inhibitor of the cytotoxic effect of diphtheria toxin. Monensin appears to block the escape of
endocytosed toxin from a vesicle to the cytoplasm. Monensin fails to protect cells from the
effects of diphtheria toxin that is bound to the cell surface and exposed to acidic medium,
suggesting that the step normally blocked by the drug is circumvented under these conditions.
The inhibition of toxin transport caused by monensin could not be relieved when monensin
was replaced by ammonium chloride, nor when ammonium chloride was again replaced by
monensin . This suggests that both drugs block the same step of toxin transport. The effect of
monensin on the transport of diphtheria toxin to the cytoplasm is consistent with the proposal
(Draper and Simon. 1980. J. Cell Biol. 87:849-854; Sandvig and Olsnes. 1980.j. Cell Biol. 87:828-
832) that the toxin is endocytosed and then, in response to an acidic environment, penetrates
through the membrane of an intracellular vesicle to reach the cytoplasm.
Diphtheria toxin (63,000 mol wt) arrests protein synthesis in
sensitive mammalian cells by enzymatically inactivating elon-
gation factor 2 in the cell cytoplasm (3, 14). A question of
interest is the mechanism by which the toxin is transported
from a receptor at the cell surface to the cytoplasm. This
pathway, which is theoretically available to biologically rele-
vant proteins, is an interesting mechanism of transmembrane
signaling because an extracellular protein is physically admit-
ted to the cytoplasm.
It was recently proposed that diphtheria toxin destined to
inhibit protein synthesis is endocytosed and encounters an
acidic environment within the vacuolar system of the cell,
where, in response to the low pH, the toxin inserts into the
vesicle membrane (4, 6, 17, 18). Fragment A, which contains
the catalytic center of the toxin, presumably translocates to the
cytoplasmic side of the vesicle membrane as a consequence of
insertion. The evidence for this is based, in part, on the
following observations: (a) Lysosomotropic amines protect cells
from the cytotoxic effects of the toxin (9, 10). These drugs
dissipate intracellular proton gradients and could prevent the
acid-dependent penetration of the toxin through a vesicle
membrane. (b) In the presence of lysosomotropic amines, the
toxin is trapped in a location that is inaccessible to antitoxin
added to cells at 4°C, probably within an intracellular vesicle
(6). (c) The protective effect of lysosomotropic amines is lost if
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toxin bound to the cell surface is exposed to medium <pH 4.7
(6, 17, 18). This can be explained if the toxin were induced to
penetrate the plasma membrane by the acidic environment. (d)
Diphtheria toxin forms ion-conducting channels in planar lipid
bilayers <pH 5.0, demonstrating that the toxin can become a
transmembrane protein in response to an acidic environment
(4). If these data have been correctly interpreted, then other
drugs that collapse proton gradients should have effects on
toxin transport similar to those of lysosomotropic amines. We
report here that the -proton ionophore monensin protects cells
from the cytotoxic activity of diphtheria toxin. The effects of
monensin on toxin transport appear identical to those of am-
monium chloride.
MATERIALS AND METHODS
Materials
Diphtheria toxin was obtained from Connaught Laboratories (Willowdale,
Ontario, Canada) and prepared as described previously (6). Monensin was
purchased from Calbiochem-Behring Corp., American Hoescht Corp., (La Jolla,
CA)andnigericin was agift from Hoffman-LaRoche (Nutley, NJ). [3H]-L-leucine
(453H, 60Ci/mM) was purchasedfrom Schwarz/MannDiv., Becton, Dickinson
Co., (Spring Valley, NY). Other chemicals, reagent grade or better, were
purchased from either Sigma (St. Louis, MO) or Matheson, Coleman, and Bell
(East Rutherford, NJ).
57All expL:riments were done with VERO cells (African Green Monkey Cells,
ATCC registry number CCL81) maintained in Dulbecco's modified Eagle's
medium with 5% fetal bovine serum as previouslydescribed (6). Protein synthesis
assays for the cytotoxic activity ofdiphtheria toxin were as described by Draper
and Simon (6), except thatthe radioactive amino acid was [4-53HI-L-leucine. The
assay medium was Dulbecco's modified Eagle's medium with 5% fetal bovine
serum buffered to pH 7.0 with 0.02 M HEPES instead of C0 2 and containing
one-fiftieth the normal amount ofL-leucine. Monensin was dissolved in ethanol
before dilution with the assay medium. The concentration of ethanol never
exceeded 0.1% and did not interfere with protein synthesis or thecytotoxic effect
ofdiphtheria toxin. All assays were done in triplicate. The standard deviation of
the mean of triplicate samples is indicated by the errorbars in all figures, except
when the symbols were larger than the standard deviation. Rabbit antitoxin
serum was prepared with formaldehyde-treated diphtheria toxin as previously
described (6).
RESULTS
Monensin Arrests the Transport of Diphtheria
Toxin to the Cytoplasm
Cells preincubated with 10 AM monensin did not respond to
10 nM diphtheria toxin within 3 h (Fig. 1, top). The effect was
diminished at 1 AM monensin and absent at 0.1 AM monensin.
Cells challenged with up to 100 nM diphtheria toxin synthe-
sized protein normally in the presence of 10 AM monensin
(Fig. 1, bottom). Monensin itself had little effect on protein
synthesis. Nigericin, an ionophore closely related to monensin,
partially protected cells from 10 nM toxin at 1 AM (data not
shown). Higher concentrations of nigericin alone abolished
protein synthesis, making it impossible to determine the dose
of nigericin that would give complete protection. Carbonyl
cyanide p-trifluoromethoxyphenylhydrazone (FCCP), a proton
transporter unrelated to monensin or nigericin, did not inhibit
the effect of the toxin on protein synthesis. Unlike monensin
and nigericin, FCCP is an electrogenic protonophore; the
electrical gradient established by proton transport is not bal-
anced by cation transport in the opposite direction. The elec-
trical gradient would oppose continued proton loss and leave
a pH gradient intact. The presence of a second cation iono-
phore, such as valinomycin, should abolish the electrical effect
and allow free proton transport; however, a combination of
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FIGURE 1 The effect of mo-
nensin on the cytotoxic activ-
ity of diphtheria toxin . Top;
cells were treated with the in-
dicated concentrations of mo-
nensin for 0.25 h and then in-
cubated with (/) or without
(") 10 nM diphtheria toxin for
3 h at 37'C. [3H]leucine was
added during the last hour of
the incubation . Bottom; cells
were treated for 0.25 h with 10
pM monensin (W or without
monensin (") and then incu-
bated for 3 h with the indi-
cated concentrations of diph-
theria toxin, the last hour dur-
ing which they received [3H]-
leucine.
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FIGURE 2
￿
The effect of antitoxin on the cytotoxic activity of diph-
theria toxin with cells that were pre-incubated with monensin and
toxin . The protocol is summarized above the graph; the cells were
pre-incubated at 37*C with 10 pM monensin for 0.25 h and exposed
to 10 nM toxin for 1 h. The cells were washed twice and antitoxin
(10 ILI of antitoxin serum) was added at either 37oC (") or 4aC (/)
for 1.0 h . After three more washes to remove all drugs, the cells were
incubated at 37'C for 23 h and exposed to [3 H]leucine for 1 h to
measure protein synthesis.
both FCCP (1.0 AM) and valinomycin (0.1 AM) inhibited
protein synthesis before any effects on the entry of the toxin
could be seen.
If monensin traps some toxin within an intracellular vesicle,
then antitoxin added to the cell exterior should not neutralize
the effects of the sequestered toxin. The temperature of the
cells when the antitoxin is applied is a critical variable in this
experiment. As described in Fig. 2, cells were preincubated
with monensin and toxin at 37°C to allow the toxin to proceed
to that step of the transport process blocked by monensin. The
cultures were then divided into two portions; antitoxin was
added to one portion at 37°C and to the other portion at 4°C.
After a 1-h incubation, the cells were washed to remove all
drugs. Protein synthesis, measured 24 h later, is shown in the
graph of Fig. 2. The cells were protected by antitoxin added at
37°C but not at 4aC. The effect of temperature is identical to
that seen when ammonium chloride is used instead ofmonensin
(6). The result at VC is expected if a fraction of the toxin is
trapped within intracellular vesicles inaccessible to antitoxin in
the medium. Upon removal ofthe monensin and antitoxin, the
trapped toxin could proceed to the cytoplasm at 37°C and
arrest protein synthesis. The same result would also be seen if
chilling the cells somehow introduced an artifact that allowed
the toxin to enter the cytoplasm. This could occur, for example,
if a vesicle containing the toxin broke open within the cell
when the temperature was lowered. To test this, cells were
preincubated with monensin and toxin, chilled to VC, exposed
to antitoxin for 0.5 h, and raised to 37°C for 2 h with antitoxin
and monensin present. If the temperature change caused the
toxin to enter the cytoplasm, then protein synthesis should
cease; however, as seen in Fig. 3, protein synthesis was normal
24 h later.How antitoxin present at 37°C in the experiments of Figs . 2
and 3 could neutralize the effects of toxin already within a
vesicle is not clear. Some process active at 37°C, but not at
4°C, is implicated . To explain a similar effect found with
ammonium chloride, Draper and Simon (6) suggested either
that the antitoxin is endocytosed and delivered to vesicles
containing the toxin or that the intracellular vesicles containing
the toxin are recycled back to the cell surface, exposing the
toxin to medium containing antitoxin . Another explanation is
that the half-life of toxin trapped within a vesicle by monensin
is very short . The antitoxin could neutralize toxin outside the
cell while toxin within intracellular vesicles is inactivated at
37°C, giving the appearance that the antitoxin somehow gained
access to intravesicular toxin . The experiment of Fig . 4 suggests
that this is not the case . Cells were pretreated with monensin
and toxin, chilled, and exposed to antitoxin . After 0 .5 h, the
antitoxin was removed but not the monensin, and the cells
were incubated at 37°C for 1 h. If the toxin was inactivated
during this time, then protein synthesis should be normal 24 h
after the monensin is removed . Protein synthesis was inhibited
as shown in barA of Fig. 4 . It is important in this experiment
that the neutralization of toxin by antitoxin be irreversible. To
test this, cells were incubated at 4°C with toxin, treated with
antitoxin, washed, and then incubated at 37°C. Protein synthe-
sis was normal 24 h later, demonstrating that the inhibitory
effect ofthe antitoxin was irreversible (data not shown) .
Monensin Fails to Protect Cells after Diphtheria
Toxin Bound to the Cell Surface Is Exposed to
AcidicMedium
The protective effect of monensin, like that of ammonium
chloride, should be lost ifdiphtheria toxin that is bound to the
cell surface penetrates the plasma membrane when exposed to
acidic medium. As seen in the graph of Fig. 5, monensin failed
to protect cells that were preincubated with toxin at 4°C,
FIGURE 3
￿
The effect of a temperature drop on diphtheria toxin that
is trapped within the cell by monensin . Cells were treated with 10
AM of monensin for 0 .5 h at 37°C and exposed for 1 h to 10 nM
toxin as shown in the summary above the graph . The cells were
then chilled and treated with 10 pl of antitoxin at 4°C . After 0 .5 h,
the cells were raised to 37°C for 2 h and washed three times to
remove all drugs . Protein synthesis, measured 24 h later, is seen in
bar A . When the toxin was omitted in this experiment, protein
synthesis was as in bar B; bar C shows protein synthesis when the
antitoxin was omitted .
FIGURE 4 The effect of a 1-h incubation at 37°C on diphtheria
toxin that is trapped within the cell by monensin . The protocol is
summarized above the graph . The cells were incubated with 10uM
monensin at 37°C for 0.25 h, followed by the addition of 10 nM
toxin for 1 h . The temperature was lowered to 4°C and 10 ftl of
antitoxin was added for 0.5 h . The cells were washed three times
with medium containing 10 AM monensin to remove the antitoxin
but retain the monensin . After a 1-h incubation at 37°C, the cells
were washed twice with medium and washed twice again 0 .5 h later
to remove the monensin . Protein synthesis 24 h later is shown by
bar A . Protein synthesis when the toxin was omitted is shown by
bar B and when the antitoxin was omitted by bar C.
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FIGURE 5
￿
The effect of monensin on the cytotoxic activity of diph-
theria toxin after cells with toxin on their surface were exposed to
acidic medium . The cells were treated according to the protocol
shown above the graph . Cells were incubated for 1 h at 4°C with 10
nM diphtheria toxin, washed twice, and exposed to medium at
different acidities for 0 .5 h at 4°C . The cells were washed again and
treated with medium at pH 7, 4°C, containing 10 AM monensin .
After 0.5 h, during which time the protective effect of monensin is
usually established, the cells were placed at 37°C for 3 h and treated
with [ 3Hlleucine for the last hour of the incubation .
exposed to medium <pH 4.7, and incubated at 37°C with
monensin . A similar effect was seen when the preincubation
included both toxin and monensin, suggesting that monensin
does not directly inhibit the toxin molecule itself . These results
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FIGURE 6
￿
The effect of concanavalin A on the cytotoxic activity of
diphtheria toxin after cells with toxin on their surface were exposed
to acidic medium . The cells were treated as described in Fig . 5
except that monensin was replaced with 50 1g/ml concanavalin A .
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FIGURE 7 A model for the analysis of the effects of different
inhibitors on the transport of diphtheria toxin to the cell cytoplasm .
To reach the cytoplasm, diphtheria toxin negotiates a series of steps
beginning at the cell surface and ending when fragment A interacts
with elongation factor 2 . Four hypothetical steps are shown above.
Consider two drugs, x and y, whose effects are reversible. Assume
in A that the drugs inhibit two different steps . When cells are
incubated with drug x and toxin, the toxin is blocked at step 2. If
drug y is then added and x removed, the toxin can proceed past
step 1 but is then blocked at step 3 . When drug x is added again
and y is removed to complete one full cycle of drug exchange, the
toxin that had passed step 2 is now free to enter the cytoplasm and
inhibit protein synthesis . Note that if drug y were added first, only
a half cycle of drug exchange would be sufficient to allow the toxin
to enter the cytoplasm . This makes it possible to order the steps
affected by two drugs with respect to one another . In B, the two
drugs inhibit the same step. The toxin should still be blocked at
step 3 after any number of drug exchanges . More complicated
situations are possible; in C, each drug inhibits two different alter-
nating steps . Two complete cycles of drug exchange would be
required to advance the toxin past step 4 and distinguish this
example from that in 8 .
are expected if the toxin directly penetrated the plasma mem-
brane in response to the acidic medium . An alternative possi-
bility is that the toxin is only primed' for penetration by the
treatment at lowpH (perhaps by a conformational change) and
that the actual penetration occurs sometime later after endo=
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cytosis . Concanavalin A arrests the endocytosis of surface-
bound diphtheria toxin (11) and protects cells from the effects
of the toxin (5) . Ifthe lectin fails to protect cells after the toxin
is exposed to a low pH at the cell surface, then endocytosis is
probably unnecessary under these conditions . The results in
Fig . 6 demonstrate that the lectin does not protect cells <pH
4.7 .
Ammonium Chloride and Monensin Inhibit the
Same Step of the Toxin Transport Process
The effects of monensin on toxin transport appear similar to
those ofammonium chloride . Both drugs neutralize intracel-
lular pH gradients, albeit by different mechanisms, and their
effects should be similar if they prevent the acid-dependent
penetration of the toxin through the membrane of a vesicle . If
both drugs actually do inhibit the same step of the transport
mechanism, it should be impossible to relieve the inhibition of
one drug by replacing it with the other; if two different steps
are affected, the inhibition ofone drug should be relieved when
it is replaced by the other. The rationale for this analysis is
described in Fig. 7 . In Fig. 8, cells were incubated with monen-
sin and toxin, then ammonium chloride was added and the
monensin was removed . The drug exchanges were repeated for
two complete cycles until monensin was the last drug present .
Protein synthesis was normal 4.5 h later as shown in bar A of
Fig . 8 . This suggests that monensin and ammonium chloride
block the same step of toxin transport . Bar B shows protein
synthesis when the toxin was omitted from the protocol . Bar C
shows that protein synthesis ceased when the last drug added,
FIGURE 8 The effect of exchanging monensin and ammonium
chloride on toxin transport . Cells were treated with 10,uM monensin
for 0 .5 h and incubated with 10 nM diphtheria toxin for 1 h at 37°C .
Then medium containing both 10 jiM monensin and 20 mM am-
monium chloride was added . 10 min later, the cells were washed
twice with medium containing only ammonium chloride . This wash
was repeated 20 min later . Control experiments showed that this
washing procedure was sufficient to reverse the effects of monensin .
30 min later, medium containing monensin and ammonium chloride
was added . After 10 min, the cells were washed twice with medium
containing only monensin . The wash was repeated 20 min later to
insure that all the ammonium chloride was removed . This drug
exchange procedure was repeated for another full cycle, as shown
in the summary above the graph, until monensin was the last drug
present . Protein synthesis 4.5 h later is shown in bar A . Bar Bshows
protein synthesis when toxin was omitted from the protocol . When
all drugs were washed away 0 .5 h after the last drug exchange of
the complete protocol, protein synthesis was inhibited as seen in
bar C.monensin, was removed along with ammonium chloride; this
demonstrates that toxin capable of arresting protein synthesis
was present throughout the experiment.
DISCUSSION
The proposal that diphtheria toxin is endocytosed and pene-
trates the membrane of a vesicle with a low internal pH was
based, in part, on the assumption that lysosomotropic amines
interfered with this process by raising the pH within the vesicle
(6, 17). An alternative is that the toxin penetrates the plasma
membrane (2) in some manner that can be blocked by these
reagents. It is important to verify whether other drugs that
abolish intracellular pH gradients have effects on toxin trans-
port that are similar to the effects of lysosomotropic amines.
Monensin is an ionophore that collapses proton gradients by
the electroneutral exchange ofa proton for a monovalent cation
(preferably sodium) across a membrane (15). Ray and Wu (16)
recently reported that monensin did not alter the sensitivity of
cells to diphtheria toxin in plating efficiency tests, but they did
not study concentrations of monensin >50 nM. We found that
protein synthesis in Vero cells was unaffected by as much as
100 nM diphtheria toxin in the presence of 10 lM monensin.
On a concentration basis, monensin is approximately one-
thousand times more potent than ammonium chloride in pro-
tecting cells from the effects of the toxin.
Monensin might inhibit the cytotoxic activity of the toxin by
blocking any one, or more, of five basic processes: (a) the
binding of the toxin to a receptor; (b) the possible penetration
of the toxin through the plasma membrane; (c) the endocytosis
of the toxin; (d) the possible penetration of the toxin through
the membrane of a vesicle; and (e) the enzymatic activity of
fragment A in the cytoplasm. The last possibility cannot be
true; toxin that is bound to the cell surface and exposed to
acidic medium inactivates elongation factor 2 in the presence
of monensin. When cells are incubated with monensin and
diphtheria toxin, a lethal amount of the toxin becomes insen-
sitive to neutralization by antitoxin, provided the cells are
exposed to the antitoxin at 4°C. It is unlikely that the change
in temperature either alters or shelters toxin on the cell surface
because the toxin binds to its receptor at 4°C and reacts in this
position with antitoxin (6). It appears that monensin either
traps the toxin in some intermediate form on its way through
the plasma membrane that is beyond inhibition by antitoxin or
that the toxin is trapped within a vesicle segregated from the
antitoxin; however, when the antitoxin is present at 37°C in
this experiment, the toxin is completely neutralized, clearly
indicating that monensin does not trap the toxin in some
intermediate form unreactive with antitoxin. These observa-
tions can be reconciled if, at 37°C, the toxin within vesicles is
recycled back to the cell surface or if antitoxin is endocytosed
and reacts with toxin already in vesicles. Both possibilities are
supported by recent reports directly demonstrating the recy-
cling of endocytosed membrane components (12, 19, 20). An-
other explanation, that the toxin within vesicles is inactivated,
is inconsistent with the results in Fig. 4. These data suggest
that, in the presence of monensin, the toxin binds to a receptor
and is endocytosed but cannot escape from a vesicle to the
cytoplasm. This behavior is identical to that seen in the pres-
ence of ammonium chloride (6).
We compared the effects of monensin and ammonium chlo-
ride on toxin transport in the experiment of Fig. 8 to see
whether both drugs do inhibit the same step of the transport
process. This analysis assumes that, if the two drugs inhibit
different steps, then enough toxin can be isolated between these
steps to inhibit protein synthesis after two full cycles of drug
exchange. The toxin failed to enter the cytoplasm, suggesting
that both drugs block the same step. Both drugs collapse proton
gradients, and the affected step is probably the acid-dependent
penetration of the toxin through a vesicle membrane.
Donovan et al. (4) demonstrated that diphtheria toxin inserts
into lipid bilayers at a low pH. It is likely that the toxin directly
penetrates the plasma membrane when bound to the cell
surface and exposed to medium at a low pH. Thus, the step
normally blocked by monensin and ammonium chloride is
provided outside of the cell, and the drugs no longer arrest
toxin entry. It is possible that the toxin must still undergo some
processing event that only occurs after endocytosis before it
can penetrate a membrane; however, we found that concana-
valin A, which inhibits the endocytosis of the toxin (11), also
fails to protect cells from toxin treated with acidic medium at
the cell surface. This suggests that a postendocytic processing
event is not required under these conditions.
The identity of the vesicles from which the toxin escapes is
not yet clear. Lysosomes are obvious candidates because their
interior pH is about 4.8 (13), but the toxin could escape from
some other compartment of the vacuolar system if it encoun-
tered a low pH. Sandvig and Olsnes (18) recently suggested
that toxin entering the lysosomes was digested before fragment
A could pass through a membrane and that the toxin may
escape before an endocytic vesicle fuses with the lysosomes.
The experiment in Fig. 6 bears on this point: after the antitoxin
was removed, the cells were incubated for 1 h at 37°C in the
presence of monensin, and the toxin was still active. We have
extended this incubation up to 4 h with similar results and also
repeated the observation with ammonium chloride (data not
shown). This is ample time for the toxin to have entered
lysosomes. Normal drug-free toxin transport, however, may be
different; the presence of the drug might protect the toxin,
perhaps by preventing the fusion of endocytic vesicles with
lysosomes, or by inhibiting lysosomal proteolysis.
Diphtheria toxin reaches the cytoplasm by a mechanism
similar to that of Semliki Forest virus (8). Other protein toxins,
and perhaps some protein hormones, might also use this path-
way. Diphtheria toxin should be an interesting model system
with which to study endocytosis and the subsequent fate of the
vesicles. In response to a low pH, diphtheria toxin undergoes
a structural change with important functional consequences.
This could also be true for some endocytosed membrane
proteins during normal cell metabolism. A possible example of
this may be recycled receptors since drugs that neutralize pH
gradients appear to arrest the reappearance ofthese membrane
components in the plasma membrane (1, 7, 21, 22).
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